SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-366322
Filing Date
2015-11-04
Accepted
2015-11-04 17:24:12
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d19736d10q.htm 10-Q 639133
2 EX-10.1 d19736dex101.htm EX-10.1 57483
3 EX-10.2 d19736dex102.htm EX-10.2 9695
4 EX-31.1 d19736dex311.htm EX-31.1 8754
5 EX-31.2 d19736dex312.htm EX-31.2 8704
6 EX-32.1 d19736dex321.htm EX-32.1 3768
  Complete submission text file 0001193125-15-366322.txt   4729715

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lnth-20150930.xml EX-101.INS 763230
8 XBRL TAXONOMY EXTENSION SCHEMA lnth-20150930.xsd EX-101.SCH 60203
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lnth-20150930_cal.xml EX-101.CAL 88147
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lnth-20150930_def.xml EX-101.DEF 226175
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20150930_lab.xml EX-101.LAB 494722
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20150930_pre.xml EX-101.PRE 367273
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 151197989
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences